Abstract
Background An asymptomatic 18-year-old female presented in December 2002 with a left pulmonary mass, and an enlarged mediastinum and left hilum, detected on a routine chest X-ray. She had never smoked, and had no history of exposure to known carcinogens, no history of serious illnesses and no family history of malignancy. Superficial lymph nodes were not palpable. A CT scan of the chest disclosed a round tumor in the left lower lobe and marked enlargement of the ipsilateral hilar and mediastinal lymph nodes.
Investigations CT scan of the chest, routine hematological study, sputum smear and culture for acid-fast bacilli, transbronchial lung biopsy, serum tumor markers, CT scan of the abdomen, MRI scan of the head, bone scintigraphy, lung function tests, blood gas analysis, pathological examination including hematoxylin–eosin staining and immunohistochemistry using chromogranin A, CD56 (neural cell adhesion molecule), and cytokeratin antibodies.
Diagnosis Limited-stage small-cell lung cancer (T1N2M0, clinical stage IIIA).
Management Etoposide plus cisplatin chemotherapy with concurrent accelerated hyperfractionated thoracic radiotherapy, left pneumonectomy and lymph-node dissection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sekine I et al. (1999) Young lung cancer patients in Japan: different characteristics between the sexes. Ann Thorac Surg 67: 1451–1455
McCambridge MM and Eliasson AH (1993) Lung cancer in the young. Ann Thorac Surg 55: 809–810
Kreuzer M et al. (1999) Occupational risk factors for lung cancer among young men. Scand J Work Environ Health 25: 422–429
Boffetta P et al. (2001) Risk of lung cancer from tobacco smoking among young women from Europe. Int J Cancer 91: 745–746
Yang P et al. (2004) Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 25: 1935–1944
Sekine I et al. (1997) Microsatellite instability in lung cancer patients 40 years of age or younger. Jpn J Cancer Res 88: 559–563
Takada M et al. (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20: 3054–3060
Noda K et al. (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346: 85–91
Kubota K et al. (2005) Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903. Clin Cancer Res 11: 5534–5538
Nugent JL et al. (1979) CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885–1893
Auperin A et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341: 476–484
Le Pechoux C and Arriagada R (2004) Prophylactic cranial irradiation in small cell lung cancer. Hematol Oncol Clin North Am 18: 355–372
Frytak S et al. (1989) Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 12: 27–33
Arriagada R et al. (1995) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87: 183–190
Davies AM et al. (2004) Treatment of recurrent small cell lung cancer. Hematol Oncol Clin North Am 18: 387–416
Shepherd FA et al. (1991) Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg 101: 196–200
Yamada K et al. (1991) A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer. Jpn J Clin Oncol 21: 39–45
Tsuchiya R et al. (2005) Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129: 977–983
Acknowledgements
We thank M Nagai for assistance with the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Yonemori, K., Kunitoh, H. & Sekine, I. Small-cell lung cancer with lymphadenopathy in an 18-year-old female nonsmoker. Nat Rev Clin Oncol 3, 399–403 (2006). https://doi.org/10.1038/ncponc0534
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0534